• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短暂丧失多梳成分会诱导表观遗传致癌命运。

Transient loss of Polycomb components induces an epigenetic cancer fate.

机构信息

Institute of Human Genetics, CNRS, University of Montpellier, Montpellier, France.

Research Institute of Molecular Pathology, Vienna BioCenter, Vienna, Austria.

出版信息

Nature. 2024 May;629(8012):688-696. doi: 10.1038/s41586-024-07328-w. Epub 2024 Apr 24.

DOI:10.1038/s41586-024-07328-w
PMID:38658752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11096130/
Abstract

Although cancer initiation and progression are generally associated with the accumulation of somatic mutations, substantial epigenomic alterations underlie many aspects of tumorigenesis and cancer susceptibility, suggesting that genetic mechanisms might not be the only drivers of malignant transformation. However, whether purely non-genetic mechanisms are sufficient to initiate tumorigenesis irrespective of mutations has been unknown. Here, we show that a transient perturbation of transcriptional silencing mediated by Polycomb group proteins is sufficient to induce an irreversible switch to a cancer cell fate in Drosophila. This is linked to the irreversible derepression of genes that can drive tumorigenesis, including members of the JAK-STAT signalling pathway and zfh1, the fly homologue of the ZEB1 oncogene, whose aberrant activation is required for Polycomb perturbation-induced tumorigenesis. These data show that a reversible depletion of Polycomb proteins can induce cancer in the absence of driver mutations, suggesting that tumours can emerge through epigenetic dysregulation leading to inheritance of altered cell fates.

摘要

虽然癌症的发生和发展通常与体细胞突变的积累有关,但许多肿瘤发生和癌症易感性的方面都存在大量的表观遗传改变,这表明遗传机制可能不是恶性转化的唯一驱动因素。然而,纯粹的非遗传机制是否足以在没有突变的情况下引发肿瘤发生一直是未知的。在这里,我们表明,由 Polycomb 蛋白介导的转录沉默的短暂扰动足以诱导果蝇中向癌细胞命运的不可逆转变。这与能够驱动肿瘤发生的基因的不可逆去抑制有关,包括 JAK-STAT 信号通路的成员和 zfh1,即 ZEB1 癌基因的果蝇同源物,其异常激活是 Polycomb 扰动诱导肿瘤发生所必需的。这些数据表明,可逆耗尽 Polycomb 蛋白可以在没有驱动突变的情况下引发癌症,这表明肿瘤可以通过导致改变的细胞命运遗传的表观遗传失调而出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/eb598390e662/41586_2024_7328_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/9292f874f0bf/41586_2024_7328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/db0afd11ae83/41586_2024_7328_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/8c659bb85b3c/41586_2024_7328_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/aa9aeafccfb5/41586_2024_7328_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/6f2d0ae22d3a/41586_2024_7328_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/6da567893e4a/41586_2024_7328_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/c40e571c520c/41586_2024_7328_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/1071f5d43391/41586_2024_7328_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/1ec9acdec524/41586_2024_7328_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/f7e8b4457abe/41586_2024_7328_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/e7375b2e1377/41586_2024_7328_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/c4df6c10afa5/41586_2024_7328_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/5b5d1d95fa10/41586_2024_7328_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/07e168adca99/41586_2024_7328_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/eb598390e662/41586_2024_7328_Fig15_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/9292f874f0bf/41586_2024_7328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/db0afd11ae83/41586_2024_7328_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/8c659bb85b3c/41586_2024_7328_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/aa9aeafccfb5/41586_2024_7328_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/6f2d0ae22d3a/41586_2024_7328_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/6da567893e4a/41586_2024_7328_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/c40e571c520c/41586_2024_7328_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/1071f5d43391/41586_2024_7328_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/1ec9acdec524/41586_2024_7328_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/f7e8b4457abe/41586_2024_7328_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/e7375b2e1377/41586_2024_7328_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/c4df6c10afa5/41586_2024_7328_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/5b5d1d95fa10/41586_2024_7328_Fig13_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/07e168adca99/41586_2024_7328_Fig14_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763b/11096130/eb598390e662/41586_2024_7328_Fig15_ESM.jpg

相似文献

1
Transient loss of Polycomb components induces an epigenetic cancer fate.短暂丧失多梳成分会诱导表观遗传致癌命运。
Nature. 2024 May;629(8012):688-696. doi: 10.1038/s41586-024-07328-w. Epub 2024 Apr 24.
2
Sustained inactivation of the Polycomb PRC1 complex induces DNA repair defects and genomic instability in epigenetic tumors.持续失活的多梳 PRC1 复合物在表观遗传学肿瘤中诱导 DNA 修复缺陷和基因组不稳定性。
Histochem Cell Biol. 2024 Jul;162(1-2):133-147. doi: 10.1007/s00418-024-02302-z. Epub 2024 Jun 18.
3
Hyd/UBR5 defines a tumor suppressor pathway that links Polycomb repressive complex to regulated protein degradation in tissue growth control and tumorigenesis.Hyd/UBR5 定义了一条肿瘤抑制途径,它将 Polycomb 抑制复合物与组织生长控制和肿瘤发生中的受调控的蛋白降解联系起来。
Genes Dev. 2024 Aug 20;38(13-14):675-691. doi: 10.1101/gad.351856.124.
4
What a tangled web we weave: crosstalk between JAK-STAT and other signalling pathways during development in Drosophila.我们编织了一张多么错综复杂的网:果蝇发育过程中JAK-STAT与其他信号通路之间的串扰。
FEBS J. 2025 Jul;292(13):3298-3320. doi: 10.1111/febs.17391. Epub 2025 Jan 16.
5
Stress-induced Cdk5 activity enhances cytoprotective basal autophagy in by phosphorylating acinus at serine.应激诱导的 Cdk5 活性通过磷酸化 acinus 的丝氨酸增强 中的细胞保护性基础自噬。
Elife. 2017 Dec 11;6:e30760. doi: 10.7554/eLife.30760.
6
Short-Term Memory Impairment短期记忆障碍
7
Deciphering TLR and JAK/STAT pathways: genetic variants and targeted therapies in COVID-19.解析Toll样受体(TLR)和JAK/STAT信号通路:新型冠状病毒肺炎中的基因变异与靶向治疗
Mol Biol Rep. 2025 Jul 18;52(1):733. doi: 10.1007/s11033-025-10843-2.
8
The Polyhomeotic protein induces hyperplastic tissue overgrowth through the activation of the JAK/STAT pathway.多效同源盒蛋白通过激活 JAK/STAT 通路诱导组织过度增生。
Cell Cycle. 2009 Dec 15;8(24):4103-11. doi: 10.4161/cc.8.24.10212. Epub 2009 Dec 30.
9
Vitamin B6 deficiency cooperates with oncogenic Ras to induce malignant tumors in Drosophila.维生素 B6 缺乏与致癌性 Ras 协同作用诱导果蝇发生恶性肿瘤。
Cell Death Dis. 2024 Jun 3;15(6):388. doi: 10.1038/s41419-024-06787-3.
10
The recognition of behaviorally distinct sleep stages in uncovers previously obscured homeostatic and circadian control of sleep.对行为上不同睡眠阶段的识别揭示了以前被掩盖的睡眠稳态和昼夜节律控制。
bioRxiv. 2025 Jul 8:2025.06.23.661143. doi: 10.1101/2025.06.23.661143.

引用本文的文献

1
The role of epigenetic regulation in cuproptosis, ferroptosis and NETosis in the pathogenesis of autoimmune diseases.表观遗传调控在自身免疫性疾病发病机制中的铜死亡、铁死亡和中性粒细胞胞外陷阱形成中的作用。
Apoptosis. 2025 Aug 21. doi: 10.1007/s10495-025-02158-1.
2
The epigenetic circle: feedback loops in the maintenance of cellular memory.表观遗传循环:细胞记忆维持中的反馈回路
Epigenetics Chromatin. 2025 Aug 20;18(1):56. doi: 10.1186/s13072-025-00621-6.
3
A subset of Polycomb-targeted transcription factor genes become hypermethylated yet upregulated in colorectal cancer.

本文引用的文献

1
Epigenetic regulation during cancer transitions across 11 tumour types.癌症在 11 种肿瘤类型中的转移过程中的表观遗传调控。
Nature. 2023 Nov;623(7986):432-441. doi: 10.1038/s41586-023-06682-5. Epub 2023 Nov 1.
2
EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma.靶向EZH2可诱导多发性骨髓瘤中CD38上调并增强对抗CD38免疫疗法的反应。
Leukemia. 2023 Sep;37(9):1925-1928. doi: 10.1038/s41375-023-01983-0. Epub 2023 Aug 2.
3
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance.
在结直肠癌中,一部分受多梳蛋白靶向的转录因子基因发生高甲基化但表达上调。
Comput Struct Biotechnol J. 2025 Aug 5;27:3556-3564. doi: 10.1016/j.csbj.2025.07.057. eCollection 2025.
4
RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications.癌症中的RNA表观遗传学:当前认知与治疗意义
MedComm (2020). 2025 Aug 3;6(8):e70322. doi: 10.1002/mco2.70322. eCollection 2025 Aug.
5
Epigenetic regulation of cancer stemness.癌症干性的表观遗传调控。
Signal Transduct Target Ther. 2025 Aug 1;10(1):243. doi: 10.1038/s41392-025-02340-6.
6
RASGEF1C methylation for the distinguishment and classification of benign and malignant thyroid tumors.用于鉴别和分类甲状腺良恶性肿瘤的RASGEF1C甲基化
Clin Epigenetics. 2025 Jul 14;17(1):124. doi: 10.1186/s13148-025-01931-y.
7
m5C-modified circRREB1 promotes lung cancer progression by inducing mitophagy.m5C修饰的环状RREB1通过诱导线粒体自噬促进肺癌进展。
J Exp Clin Cancer Res. 2025 Jul 14;44(1):203. doi: 10.1186/s13046-025-03460-1.
8
JCMM Annual Review on Advances in Biotechnology for the Treatment of Haematological Malignancies: A Review of the Latest In-Patient Developments 2024-2025.《JCMM关于血液恶性肿瘤治疗生物技术进展的年度回顾:2024 - 2025年最新住院治疗进展回顾》
J Cell Mol Med. 2025 Jul;29(13):e70700. doi: 10.1111/jcmm.70700.
9
Structural characteristics and SARs of EZH2 inhibitors.EZH2抑制剂的结构特征与构效关系
Mol Divers. 2025 Jul 1. doi: 10.1007/s11030-025-11272-w.
10
DNA Methylation, Aging, and Cancer.DNA甲基化、衰老与癌症。
Epigenomes. 2025 Jun 3;9(2):18. doi: 10.3390/epigenomes9020018.
BLM 解旋酶是多发性骨髓瘤中涉及复制应激存活和耐药性的新的治疗靶点。
Front Immunol. 2022 Dec 9;13:983181. doi: 10.3389/fimmu.2022.983181. eCollection 2022.
4
DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of synthetic enhancers.DeepSTARR 可根据 DNA 序列预测增强子活性,并能够从头设计合成增强子。
Nat Genet. 2022 May;54(5):613-624. doi: 10.1038/s41588-022-01048-5. Epub 2022 May 12.
5
Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis.全基因组CRISPR筛选确定PRC2和KMT2D-COMPASS是不同上皮-间质转化轨迹的调节因子,它们对转移的贡献存在差异。
Nat Cell Biol. 2022 Apr;24(4):554-564. doi: 10.1038/s41556-022-00877-0. Epub 2022 Apr 11.
6
DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.基于 DNA 甲基化的结直肠癌诊断、预后和预测生物标志物。
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188722. doi: 10.1016/j.bbcan.2022.188722. Epub 2022 Mar 17.
7
Comprehensive characterization of the epigenetic landscape in Multiple Myeloma.全面描绘多发性骨髓瘤的表观遗传学特征。
Theranostics. 2022 Jan 16;12(4):1715-1729. doi: 10.7150/thno.54453. eCollection 2022.
8
Mechanisms of Polycomb group protein function in cancer.多梳蛋白复合物功能在癌症中的作用机制。
Cell Res. 2022 Mar;32(3):231-253. doi: 10.1038/s41422-021-00606-6. Epub 2022 Jan 19.
9
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
10
Non-genetic determinants of malignant clonal fitness at single-cell resolution.单细胞分辨率下恶性克隆适应性的非遗传决定因素。
Nature. 2022 Jan;601(7891):125-131. doi: 10.1038/s41586-021-04206-7. Epub 2021 Dec 8.